Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 290

1.

α-Smooth muscle actin-positive myofibroblasts, in association with epithelial-mesenchymal transition and lymphogenesis, is a critical prognostic parameter in patients with oral tongue squamous cell carcinoma.

Ding L, Zhang Z, Shang D, Cheng J, Yuan H, Wu Y, Song X, Jiang H.

J Oral Pathol Med. 2014 May;43(5):335-43. doi: 10.1111/jop.12143. Epub 2013 Dec 9.

PMID:
24313357
2.

A role for cancer-associated fibroblasts in inducing the epithelial-to-mesenchymal transition in human tongue squamous cell carcinoma.

Zhou B, Chen WL, Wang YY, Lin ZY, Zhang DM, Fan S, Li JS.

J Oral Pathol Med. 2014 Sep;43(8):585-92. doi: 10.1111/jop.12172. Epub 2014 Mar 20.

PMID:
24645915
3.

Tumor budding correlates with poor prognosis and epithelial-mesenchymal transition in tongue squamous cell carcinoma.

Wang C, Huang H, Huang Z, Wang A, Chen X, Huang L, Zhou X, Liu X.

J Oral Pathol Med. 2011 Aug;40(7):545-51. doi: 10.1111/j.1600-0714.2011.01041.x. Epub 2011 Apr 12.

4.

T-box transcription factor Brachyury expression is correlated with epithelial-mesenchymal transition and lymph node metastasis in oral squamous cell carcinoma.

Imajyo I, Sugiura T, Kobayashi Y, Shimoda M, Ishii K, Akimoto N, Yoshihama N, Kobayashi I, Mori Y.

Int J Oncol. 2012 Dec;41(6):1985-95. doi: 10.3892/ijo.2012.1673. Epub 2012 Oct 17.

5.

Cyclo-oxygenase-2 expression is associated with vascular endothelial growth factor C expression and lymph node metastasis in oral squamous cell carcinoma.

Kono M, Watanabe M, Abukawa H, Hasegawa O, Satomi T, Chikazu D.

J Oral Maxillofac Surg. 2013 Oct;71(10):1694-702. doi: 10.1016/j.joms.2013.04.015. Epub 2013 Jul 1.

PMID:
23809761
6.

Blocking PI3K/Akt signaling attenuates metastasis of nasopharyngeal carcinoma cells through induction of mesenchymal-epithelial reverting transition.

Jiang H, Gao M, Shen Z, Luo B, Li R, Jiang X, Ding R, Ha Y, Wang Z, Jie W.

Oncol Rep. 2014 Aug;32(2):559-66. doi: 10.3892/or.2014.3220. Epub 2014 May 29.

PMID:
24889918
7.

[Association between lymphangiogenesis and clinicopathological features and prognosis in laryngeal carcinoma].

Zou JD, Fu HY, Xu W, Lü ZH, Cao HY, Luan XY.

Zhonghua Zhong Liu Za Zhi. 2011 Jun;33(6):461-4. Chinese.

PMID:
21875489
8.

Perineural invasion and expression of nerve growth factor can predict the progression and prognosis of oral tongue squamous cell carcinoma.

Shen WR, Wang YP, Chang JY, Yu SY, Chen HM, Chiang CP.

J Oral Pathol Med. 2014 Apr;43(4):258-64.

PMID:
24822265
9.
10.

Role of stromal myofibroblasts in invasive breast cancer: stromal expression of alpha-smooth muscle actin correlates with worse clinical outcome.

Yamashita M, Ogawa T, Zhang X, Hanamura N, Kashikura Y, Takamura M, Yoneda M, Shiraishi T.

Breast Cancer. 2012 Apr;19(2):170-6. doi: 10.1007/s12282-010-0234-5. Epub 2010 Oct 27.

PMID:
20978953
11.

The relationship between Bmi-1 and the epithelial-mesenchymal transition in lung squamous cell carcinoma.

Huang J, Qiu Y, Chen G, Huang L, He J.

Med Oncol. 2012 Sep;29(3):1606-13. doi: 10.1007/s12032-011-9998-5. Epub 2011 Jun 8.

PMID:
21656027
12.

Expression of epithelial-mesenchymal transition markers at the invasive front of oral squamous cell carcinoma.

Costa LC, Leite CF, Cardoso SV, Loyola AM, Faria PR, Souza PE, Horta MC.

J Appl Oral Sci. 2015 Mar-Apr;23(2):169-78. doi: 10.1590/1678-775720140187.

13.

Vimentin expression of esophageal squamous cell carcinoma and its aggressive potential for lymph node metastasis.

Jin H, Morohashi S, Sato F, Kudo Y, Akasaka H, Tsutsumi S, Ogasawara H, Miyamoto K, Wajima N, Kawasaki H, Hakamada K, Kijima H.

Biomed Res. 2010 Apr;31(2):105-12.

14.

Cyr61/CCN1 overexpression induces epithelial-mesenchymal transition leading to laryngeal tumor invasion and metastasis and poor prognosis.

Liu Y, Zhou YD, Xiao YL, Li MH, Wang Y, Kan X, Li QY, Lu JG, Jin DJ.

Asian Pac J Cancer Prev. 2015;16(7):2659-64.

15.

Predictive markers for late cervical metastasis in stage I and II invasive squamous cell carcinoma of the oral tongue.

Lim SC, Zhang S, Ishii G, Endoh Y, Kodama K, Miyamoto S, Hayashi R, Ebihara S, Cho JS, Ochiai A.

Clin Cancer Res. 2004 Jan 1;10(1 Pt 1):166-72.

16.

Prognostic value of LYVE-1-positive lymphatic vessel in tongue squamous cell carcinomas.

Matsumoto N, Mukae S, Tsuda H, Sawada A, Okazaki Y, Nagai K, Akishima-Fukasawa Y, Ohki H, Ishikawa Y, Ishii T, Komiyama K.

Anticancer Res. 2010 Jun;30(6):1897-903.

PMID:
20651332
17.

Expression of E-cadherin and vimentin in oral squamous cell carcinoma.

Zhou J, Tao D, Xu Q, Gao Z, Tang D.

Int J Clin Exp Pathol. 2015 Mar 1;8(3):3150-4. eCollection 2015.

18.

Overexpression of Hippo pathway effector TAZ in tongue squamous cell carcinoma: correlation with clinicopathological features and patients' prognosis.

Wei Z, Wang Y, Li Z, Yuan C, Zhang W, Wang D, Ye J, Jiang H, Wu Y, Cheng J.

J Oral Pathol Med. 2013 Nov;42(10):747-54. doi: 10.1111/jop.12062. Epub 2013 Mar 29.

PMID:
23551691
19.

Clinical significance of lymphatic and blood vessel invasion in oral tongue squamous cell carcinomas.

Michikawa C, Uzawa N, Kayamori K, Sonoda I, Ohyama Y, Okada N, Yamaguchi A, Amagasa T.

Oral Oncol. 2012 Apr;48(4):320-4. doi: 10.1016/j.oraloncology.2011.11.014. Epub 2011 Dec 16.

PMID:
22178206
20.

[Comparison of epithelial-mesenchymal transition-related markers between cancer tissue and tumor emboli].

He N, Wu GF, Zhao HY, Han HX.

Zhonghua Bing Li Xue Za Zhi. 2011 Nov;40(11):758-61. Chinese.

PMID:
22336160
Items per page

Supplemental Content

Write to the Help Desk